- Release Date: 17/10/12 19:22
- Summary: MEETING: MLN: MLN - Non-binding proposed resolution
- Price Sensitive: No
- Download Document 23.01KB
MLN 17/10/2012 17:22 MEETING REL: 1722 HRS Marlin Global Limited MEETING: MLN: MLN - Non-binding proposed resolution 17 October 2012 Dear Shareholder Resolution proposed by Elevation Capital Management Limited for consideration at the Annual Shareholders' Meeting Introduction Marlin has received a proposal dated 15 October 2012 from Elevation Capital Management Limited (Elevation Capital). The proposal is that a resolution be put to shareholders at the Annual Shareholders' Meeting (to be held on 1 November 2012) that the Board terminates the current management agreement with Fisher Funds, and returns all capital to shareholders. The Independent Directors of Marlin do not support the Elevation Capital proposal and urge shareholders to vote against it. Elevation Capital is the manager of the Elevation Capital Value Fund, which is a shareholder in Marlin, having purchased shares in September 2012. The attached letter from Elevation Capital sets out its proposed resolution and an explanation from Elevation Capital in relation to its proposal. Marlin Independent Directors Do Not Support the Elevation Capital Proposal The Independent Directors are firmly of the view that the interests of shareholders are best served by continuing to operate the Company and not by winding it up and returning the recovered capital to shareholders. The reasons the Independent Directors do not support the proposal are: o Marlin continues to provide a unique opportunity for New Zealand investors to invest in a portfolio of global small-cap stocks managed by an experienced and highly respected investment manager. The Independent Directors believe that shareholders should focus on the prospects for Marlin to provide them with capital growth and dividends over the long term. All shareholders will be aware of the turmoil in global equity markets over recent years. Despite this, Marlin has been the best performing of 29 comparable New Zealand portfolio investment entities investing internationally since inception. The Independent Directors believe that Marlin is well placed to provide superior returns to shareholders as global equity markets recover. o Marlin shares are publicly traded. All shareholders are free to buy and sell as they please. There is no need to wind up the Company for shareholders to access their capital. o Elevation Capital focuses on the differential between the Marlin share price (70 cents as at 15 October 2012) and the Net Asset Value (NAV) of the Company (83 cents as at 9 October 2012). This is a differential of 16%. Elevation Capital states that shareholders could receive 81 cents per share if the Company was wound up and capital distributed. Shareholders should note the following: o Based on advice received from KPMG in 2009 in response to a similar shareholder proposal and advice from the Manager, the Independent Directors believe that shareholders could get a payout materially lower than the 81 cents per share suggested by Elevation Capital. Costs likely to be incurred in the winding up of Marlin include trading costs as the portfolio is sold, the manager's termination fee, legal costs and the costs associated with calling an extraordinary meeting and commissioning an independent report. o A differential between the share price of a Company and its NAV is not unusual in listed investment companies. There is nothing extraordinary about the current situation, indeed the discount has narrowed over the past two years. The current discount certainly does not warrant anything as extreme as winding up the Company. The Manager and Directors have implemented capital management initiatives that have reduced the average discount from 25% prior to the introduction of the quarterly distribution policy in August 2010 to 14% since, and continue to look to find ways to reduce it further. o Marlin has a Manager in place whose performance compares extremely favourably to managers of similar funds. As noted earlier, the review of the Manager's performance since inception in 2007 to 31 May 2012, conducted as part of the recent management contract renewal process, ranked Marlin as a top performer of 29 New Zealand portfolio investment entities investing internationally over that timeframe. Independent research house Morningstar noted in its report of 4 October 2012 that "Marlin is one of the few international equities options based out of New Zealand, and we think it's a great catch". o Finally, the Independent Directors also note that Elevation Capital (a competing fund manager) has only been a Marlin shareholder for a matter of weeks. Shareholders are encouraged to look past this short term opportunism and focus on the unique opportunity Marlin offers them, the underlying and undoubted quality of the Manager and the strong results relative to other international equity options that have been achieved in extremely difficult markets. Comments from the Manager, Fisher Funds Management Limited The Independent Directors have requested Fisher Funds Management Limited to provide its views on the comments made in Elevation Capital's letter. A letter from Fisher Funds Management is attached. Other Comments on Elevation Capital's Proposal In addition to our view that Elevation Capital's proposal should not be supported, there are some other aspects of the proposal we draw to your attention. o The resolution proposed by Elevation Capital is a resolution relating to the management of the Company and, if it was passed, it would not be a binding resolution. o The Board of the Company does not have rights to terminate the Management Agreement except on the occurrence of certain events such as the liquidation, receivership or insolvency of the Manager or material breach, gross negligence or serious misconduct by the Manager in the performance of its duties. None of those events have occurred. o With the initial term of the Management Agreement due to expire on 1 November 2012, the Board of the Company has already conducted a comprehensive review process, and as announced to the NZX, the Management Agreement has been renewed for a further five years to 1 November 2017. The Company's ability not to renew would only have arisen if the Company had been dissatisfied with the Manager's performance after discussions with the Manager, had then commissioned an independent expert's review of the Manager's performance, sent a summary of that review to shareholders and obtained shareholder approval to the non-renewal. o If all capital was to be returned to shareholders, approval of shareholders by special resolution would be required (which would require approval by 75% or more of the votes cast on a specific special resolution to that effect). Additional Proxy/Voting Form Also enclosed is an additional proxy/voting form in relation to the resolution proposed by Elevation Capital. If you wish to appoint a proxy to vote on that resolution please complete and return that form in accordance with the directions on the form. The Independent Directors are firmly of the view that the interests of Marlin shareholders are best served by continuation of the Company and, as stated earlier, we encourage shareholders to vote against this resolution proposed by Elevation Capital. If you are unable to attend the meeting we encourage you to appoint a proxy to vote on your behalf by completing and returning the enclosed proxy form. Yours sincerely Alistair Ryan Chairman Carol Campbell Director Marlin Global Limited Attn: The Chairman PO Box 33549 Takapuna Auckland 15 October 2012 Resolution proposed by Elevation Capital Management Limited - Manager of the Elevation Capital Value Fund which is a shareholder in Marlin Global Limited ("Marlin Global"). "That the Board of Marlin Global Limited (MLN:NZX) terminate the current management contract and return all capital to shareholders at Net Asset Value less costs of termination, impairments and portfolio liquidation." Explanation: As long-standing Marlin Global Shareholders will know an investment in Marlin Global has been disappointing for a number of reasons: (i) Since inception, Marlin Global has traded at a persistent and sizeable discount to Net Asset Value (NAV). This is despite the Board putting in place a share buy-back and quarterly dividend policy. In our opinion, shareholders have little prospect of seeing the current discount close if the status quo prevails. The chart below is sourced from Marlin Global's own website (www.marlin.co.nz) and vividly illustrates the persistent and sizeable nature of the discount. (ii) In June 2009, Mr Gary Cross proposed converting Marlin Global from a listed investment company to an open-end fund (managed fund) as a means to address the sizeable and persistent discount at the time. An independent report by KPMG was commissioned by the Board in September 2009 to review Mr Cross's proposal. It is interesting to review the Independent Report at this time. KPMG commented on page 4 of the report that - "In our view, the objective sought by the Cross Proposal, being the reduction and/or elimination of the discount to NAV may also be promoted by other means such as share-buybacks, implementing a managed dividend policy, delisting and wind-up of Marlin or a combination(s) of these options." Since this Independent Report was published the Board has implemented share buy-backs and a managed dividend policy and still a sizeable discount to NAV prevails. Based on the persistence and size of the discount we believe there are limited options left for the Board to consider other than delisting and wind-up as KPMG have previously suggested. (iii) Since inception, Marlin Global has clearly failed to reach or beat the performance benchmark (on a cumulative basis) established on page 3 of the Prospectus (dated 3 October 2007) and detailed in the most the recent Annual Report for the year ending 30 June 2012 (page 52). This performance benchmark is detailed as the "Change in the NZX 90 Day Bank Bill Index during the calculation period plus 5% per annum." We would also point out that there is no graphical presentation of the performance benchmark versus Marlin Global in any recent update or on the Company website which as a shareholder we would like to know why or where it is located? We have sourced the chart below from Morningstar Direct, which details the NZX 90 Day Bank Bill Index plus 5% per annum versus the Marlin Global share price, which illustrates the sizeable underperformance a shareholder has experienced versus the performance benchmark (on a cumulative basis) set out in the Prospectus. (iv) Marlin Global has also failed to beat the MSCI Global Small Cap Gross Index (NZD) as detailed in the August 2012 monthly update published on the Marlin Global website. According to this document, Marlin Global has delivered a Total Shareholder Return*(since inception) for the period ending 31 August 2012 of -14% versus the MSCI Global Small Cap Gross Index (NZD) -7.9%. (*Assumes all dividends are reinvested, but excludes imputation credits.) (v) Marlin Global has also underperformed other international equity offerings available to New Zealand investors since its inception and while we acknowledge differing strategies, we would point out that Marlin's performance (total return) has been aided by the introduction of the dividend policy, which sees the company distribute 2% of the average unaudited NAV in dividends per quarter (rather than just distributing the income earned off its investments). With the income stream from investments below 2% of Marlin Global's unaudited NAV per quarter, Marlin Global is essentially (at present) selling assets and returning capital to shareholders to meet these obligations. While we acknowledge this results in a high yield, we can see no reason why this return of capital is not expedited and all capital is returned to shareholders rather than a drawn out process, which exposes investors to further market and manager risk with the underlying investments and erosion of capital via a high total cost of operation. (vi) Marlin Global (in our opinion) has a high cost of operation with a Total Expense Ratio (TER)averaging 2.48% since inception. Refer the table below, which sources all data from Marlin Global Annual Reports. FY12 FY11 FY10 FY09 FY08 Average Total Equity(NZ$mln) 91.218 108.527 106.384 100.431 94.932 Total Expenses(NZ$mln) 1.747 2.867 3.623 2.339 1.319 TER*(%) 1.92% 2.64% 3.41% 2.33% 2.08%** 2.48% *Elevation Capital Management Limited calculations/**Annualised (vii) Marlin Global has recently appointed a new portfolio manager and while we acknowledge this person's experience, a "wait and see" approach and renewal of the current management contract on this basis is not satisfactory (in our opinion) for long suffering Marlin Global shareholders. Should shareholders vote in favour of this resolution we estimate the value uplift from the current Marlin Global share price of NZ$ 0.70 cents per share (cps) as a result of termination of the management contract, impairments and liquidation of the portfolio would result in a 15.71% return to shareholders, subject to market conditions and actual costs. (Note: we have estimated NZ$0.0234cps for the cost of termination, impairment and portfolio liquidation which should result in a net return of NZ$ 0.8100cps compared to a published NAV of NZ$ 0.8334 as at 9 October 2012, subject to market conditions and actual costs.) We look forward to seeing shareholders and the Board of Marlin Global on Thursday, 1 November 2012 (10:30am) at the ASM and we would be happy to present to shareholders the facts that we have summarised in this letter. Yours sincerely, Christopher Swasbrook Managing Director Elevation Capital Management Limited 17 October 2012 Dear Shareholder Fisher Funds' view on the Elevation Capital Proposal We view the proposal from Elevation Capital Management Limited (Elevation Capital) as an opportunistic attempt by a competitor of Fisher Funds and Marlin Global (Marlin), to attract new clients and raise its profile as a shareholder activist. Fisher Funds rejects the Elevation Capital proposal and urges shareholders to vote against it. In our view, the proposal from Elevation Capital should not be supported for the following reasons: 1. Elevation Capital is a small and very recent Marlin shareholder with a history of attempts to achieve short-term gains by seeking to wind up or return capital from Australasian listed companies. These hostile approaches have been aimed at making one-off gains for Elevation Capital's investors rather than supporting the broader shareholder interests of the target companies. 2.Investors participated in the Marlin IPO on the basis of having a long-term investment focus. Winding up Marlin just five years after its inception would be contrary to the objectives of the company and its shareholders. Marlin shareholders who have been patient throughout the global financial crisis should not have the opportunity to achieve their long-term investment objectives removed, in order to make a one-off and relatively limited gain. Addressing specific points raised by Elevation Capital Elevation Capital Statement: Para (i) "Shareholders have little prospect of seeing the current discount close if the status quo prevails". Many companies and most listed investment companies trade at a discount to NAV. This is not a new phenomenon and does not mean that long-term value can't be generated for shareholders while a discount exists. The discount is more transparent for Marlin than many operational companies because it is published each week. If every listed company was wound up when a short-term gain could be made upon realisation of the underlying assets, New Zealand would have a very small capital market. Decisions about wind up must be made on the basis of long-term potential for shareholder value not short-term, opportunistic gains based on a relatively modest discount. We challenge Elevation Capital's statement that the discount will not close. The Marlin Board has taken steps to close the discount in the past which has had a significantly positive effect on the discount. In addition, when appetite in the broad market or interest in a particular stock increases, the discount can close quickly. We see no reason why that would not happen in future. As an example, appetite for the New Zealand share market has returned and the discount of Marlin's sister company, Kingfish Limited, which was as high as 39% in 2007 had narrowed to 8.5% at 30 September 2012. It is also worth remembering that not all of Marlin shareholders bought at IPO. More than 1,000 shareholders, including Elevation Capital, have purchased their Marlin shares at a discount. Some of those shareholders have already enjoyed the benefits of the discount subsequently narrowing. The following table highlights how the Marlin discount has differed each financial year. It has reduced substantially as the board has introduced new capital management initiatives and as markets have recovered. Financial year to 30 June Average Discount 2008 21.37% 2009 31.65% 2010 20.68% 2011 13.68% 2012 14.78% Elevation Capital Statement: Para (iii) "Marlin has clearly failed to reach or beat the performance benchmark..." This statement is simply not true. Fisher Funds has received performance fees for Marlin, and these are only paid if our performance (audited and measured by the change in NAV) exceeds the performance benchmark. Performance fees have been earned despite the Marlin performance hurdle (NZX 90 Day Bank Bill plus 5% per annum) being the highest of comparable funds available in the New Zealand market. Elevation Capital wrongly compares the Marlin share price with the performance benchmark. Elevation Capital Statement: Para (v) "Marlin has also underperformed other international equity offerings..." The Marlin Board has already conducted research on Fisher Funds' performance as part of its process in considering renewal of the management agreement. A summary of the results of that review are attached in Appendix 1. We believe it is misleading to compare Marlin with other companies that have completely different investment strategies. That is akin to saying that Telecom should be wound up because it has under-performed other New Zealand shares on the market, such as Ryman Healthcare, even though both companies clearly operate in completely different sectors. Elevation Capital Statement: Para (v) "Marlin Global is essentially (at present) selling assets and returning capital to shareholders to meet these obligations... we can see no reason why this return of capital is not expedited and all capital is returned to shareholders rather than a drawn out process". The reasons the capital should not be returned to shareholders immediately are that: 1. Shareholders have embraced the dividend policy of Marlin and regularly advise Fisher Funds and the Board that they enjoy the attractive and consistent yield on their investment. There are relatively few investments with similar yields on the New Zealand share market. 2. Returning capital would remove the significant opportunity that exists for shareholders to achieve capital gains in the future - both through a narrowing of the discount and through strong market and portfolio performance. To illustrate this point, after the proposal was presented by Gary Cross to wind up the company in July 2009, the total shareholder return was 44% over the following two years. The discount immediately prior to the proposal was 25%. The Board and shareholders would clearly have been unwise to accept a short-term gain of less than 20% rather than enjoying a longer term gain of double that amount. Elevation Capital Statement: Para (vi) "Marlin Global ... has a high cost of operation with a Total Expense Ratio (TER) averaging 2.48% since inception". Marlin's costs are higher than comparable unlisted funds due to listing costs and corporate governance, but are lower than similar investment vehicles available internationally. It is worth noting that the 2010 TER was adversely affected by the costs associated with the Cross proposal and that both the 2010 and 2011 TERs included performance fees (despite Elevation Capital's suggestion that Marlin has never outperformed the performance benchmark). The 2012 and 2008 TERs are based on a reduced management fee of 0.75% of gross asset value. This is an important and unique feature of Marlin's fee structure - Fisher Funds receives a lower management fee in the event that it achieves a return less than the deposit rate. No other fund manager in New Zealand offers investors the same alignment of interests. Elevation Capital Statement: Para (vii) "Marlin Global has recently appointed a new portfolio manager and while we acknowledge this person's experience ... renewal of the management contract on this basis is not satisfactory (in our opinion) for long suffering Marlin Global shareholders". We challenge the grounds for Elevation Capital's statement that Marlin Global shareholders are "long suffering". This statement is certainly contrary to the feedback we receive from shareholders, particularly those who have experienced Marlin's longer-term outperformance. A shareholder who bought at IPO and sold out in the first four months of this year would have received a positive total shareholder return of between 1.5% and 5.3% return (depending on the month they sold). This is hardly "suffering", and is a creditable achievement given the difficult market environment that has prevailed during Marlin's lifetime. The Manager of Marlin is Fisher Funds. While investment personnel may change from time to time, as has been the case with the resignation of Ken Applegate and the appointment of Roger Garrett as the new portfolio manager, the same investment strategy and philosophy has been applied to the Marlin portfolio during the transition process. Rather than a cause for criticism, we believe the transition to a new and very experienced international investment team has ensured continuity of management and minimal distruption. Marlin Global remains a unique, hand-picked portfolio of international growth companies managed by a team of investment professionals with a time-tested investment approach. We look forward to meeting you at the Annual Shareholders Meeting and encourage you to vote against this opportunistic proposal. Yours sincerely Carmel Fisher Managing Director (Carmel Fisher is an executive director of Marlin and is also a director and shareholder of Fisher Funds Management Limited). Appendix 1: Morningstar Review of Marlin Global Performance As part of the Marlin management agreement renewal process, the Board of Marlin has sourced data from Morningstar which has been reviewed by an independent actuary and shows that Marlin's performance to be ahead of its peers over 5 years. Marlin's performance is ranked 1st out of 24 over 5 years and 14th out of 27 over three years compared with similar-sized and structured international domiciled small cap funds: Additionally, Marlin's performance is ranked 1 out of 29 over 5 years and 12th out of 40 when compared with similar-sized and structured New Zealand domiciled portfolio investment entities investing in equities internationally (all data is to 31 May 2012): End CA:00228564 For:MLN Type:MEETING Time:2012-10-17 17:22:44
Ann: MEETING: MLN: MLN - Non-binding proposed res
Add to My Watchlist
What is My Watchlist?